chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse concerning a 15 year old male with no pertinent medical history and no drug allergies, who on 19-MAR-2010 was vaccinated with the first dose of VARIVAX (Merck) (0.5ml, SC, lot # 665763/1296Y) and later that day had a fever. There was no concomitant medication. He awoke with a rash on 01-APR-2010 and was seen in the office. On exam he had less than 50 lesions scattered on his trunk, back and face. Diagnosis was chickenpox. There were no labs or diagnostic tests performed. The patient's chickenpox persisted. Follow up information has been received from a registered nurse concerning a 15 year old male student with no illness at time of vaccination and no drug allergies, who on 19-MAR-2010 at p.m. was vaccinated with the first dose of VARIVAX (Merck) (SC, lot # 665763/1296Y) in the right deltoid. On the same day, the patient was also vaccinated with the first dose of ADACEL (Sanofi, lot # UF544AA) IM in the right deltoid and the first dose of MENACTRA (Sanofi, lot # U3054AA) IM in the left deltoid at p.m. The patient had a fever after receiving immunization on 19-MAR-2010. On 01-APR-2010 he noticed a generalized rash on his trunk and face with lesions similar to chickenpox. The patient did not seek medical attention and recovered on 05-APR-2010. No further information is available.
Narrative:  The patient received two doses of Pfizer vaccine in Jan 2021. The patient test positive for COVID 19 on 17 October 2021 and was hospitalized with weakness, myalgia, urinary tract infection, covid pneumonia and arrhythmia. The patient was treated and discharged on 26 October 2021. Reported per EUA.
20 min. after getting vaccine pt started to say they felt like there was a bunch of ants crawling on him and he had red cheeks. He also stated that he couldn't feel his knee. He did vomit, feel dizzy and his head hurt. He was given 10 ml of Benadryl and saw slight improvement  but patient still said his he could not feel his knee. Dr. did look patient over and mom stated she would have to take patient in either was so she wanted the emergency department called. They ended up showing up and assessed the patient and mom said that she will take the pt to the ER
7 days after injection, injection site became bright red, itchy, hot to the touch, swollen with a hard lump under the skin and the redness began to spread over  upper arm.  Took Zyrtec, Benadryl (2 doses over a 5 hr time frame), topical hydrocortisone (x2) and placed ice on the area the evening of 1/13. The morning of 1/14 the redness had spread, area was still hot to the touch, itchy. Took Zyrtec the morning of 1/14. The evening of 1/14, iced area and took Benadryl. The morning of 1/15 redness beginning to fade- area did not spread, took Zyrtec.
PATIENT COMPLAINED OF NAUSEA AND FEELING FAINT 7  MINUTES AFTER VACCINE GIVEN. BROUGHT TO TRIAGE #2 WHERE SHE WAS OBSERVED TO BE DIAPHORETIC.  BP: 80/32, HR 63, O2 SAT96% ROOM AIR SHE WAS MONITORED WITH 2ND SET OF VS TAKEN WITH BP: 101:48, HR 54, O2 SAT 96% ROOM AIR,  SYMPTOMS RESOLVED AND SHE WAS RELEASED.
went to bed at 10, and was cold but that's normal.  about 12am was getting colder and back hurt.  went to couch with heating pad, was so terribly tired, little nauseous, went to bathroom 8times.  got up at 6am with husband and crawled into bed and slept, didnt hear anything happening in the house, just slept.  got up to couch again and heating pad, then bed again.  freezing and warm and sweating head.  at 12 noon finally 'woke' up and got up and sat on couch but didn't feel need to sleep as much.  ate a little at 1pm, now am sweating like a fever broke, not cold anymore.  headache yet, stiff neck, arm sore
This case was reported by a other health professional via call center representative and described the occurrence of injection site pain in a 50-year-old female patient who received SHINGRIX (batch number 49R72, expiry date 13th March 2021) for prophylaxis. On 29th November 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain, injection site lump, injection site erythema and injection site itching. On an unknown date, the outcome of the injection site pain, injection site lump, injection site erythema and injection site itching were recovered/resolved. It was unknown if the reporter considered the injection site pain, injection site lump, injection site erythema and injection site itching to be related to SHINGRIX. Additional details were provided as follows: The health care professional reported that patient experienced pain and a knot at the injection site that lasted 2 days and redness and itching encompassing the upper vaccinated arm that lasted 3 weeks following the 1st dose of SHINGRIX.
lost the ability to walk; was in so much pain she wanted to die; high blood pressure; didn't feel well; This spontaneous case was reported by a consumer and describes the occurrence of GAIT INABILITY (lost the ability to walk) and PAIN (was in so much pain she wanted to die) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced GAIT INABILITY (lost the ability to walk) (seriousness criterion hospitalization), PAIN (was in so much pain she wanted to die) (seriousness criterion hospitalization), HYPERTENSION (high blood pressure) and MALAISE (didn't feel well). At the time of the report, GAIT INABILITY (lost the ability to walk), PAIN (was in so much pain she wanted to die), HYPERTENSION (high blood pressure) and MALAISE (didn't feel well) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported. Treatment medication includes Antibiotics.  Company Comment: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
received Moderna COVID-19 injection past the 6-hour time expiration; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received Moderna COVID-19 injection past the 6-hour time expiration) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 15-Mar-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received Moderna COVID-19 injection past the 6-hour time expiration). On 15-Mar-2021, EXPIRED PRODUCT ADMINISTERED (received Moderna COVID-19 injection past the 6-hour time expiration) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-046684, MOD-2021-046516, MOD-2021-046415, MOD-2021-046260, MOD-2021-046182 (Patient Link).; Sender's Comments: This report refers to a case of Expired Product Administered for mRNA-1273 (Lot #: 014M20A)  with no associated AEs.
About 1 1/2 hours after the injection, I felt pain at injection site, weakness in my entire arm and noticable feeling in my thumb and index finger. About 2 1/2 hours later, I was not able to raise my arm. I have very limited range of motion
Patient displayed about a 4 inch red area on the arm he received his shot.  It is itchy. He first noticed it on 4/1/2021 and still has it today 4/3/2021.  Patient received the shot 3/18/2021.
swelling in lymph nodes under both arms, fever, fatigue, loss of appetite, nausea, itchy red area on both arms
I had a sore throat that developed into congestion, mild fever, and sinus issues. I called my doctor and they said because I did not have a cough it was probably not COVID. They thought it was just a virus going around. I had a COVID test, and it was negative. I recovered in about a week. A couple of weeks later I developed a dry cough which was worse when I slept. I took a couple COVID tests, and they were negative. In September I talked to my doctor, and they prescribed a couple medications to try to calm down the cough. The medications they gave me helped with the cough, but I still have it. I also went to a wedding over the summer and a lot of my friends who went to the wedding also developed a cough and they have had negative COVID tests as well.
CHIEF COMPLAINT: 64 years old gentleman who was recently admitted at another facility with Covid infection discharged 4 days ago presents with shortness of breath  HISTORY OF PRESENT ILLNESS: He tested positive for Covid on the 13th of this month (July) and had been at a Medical Center up until last Friday.  He did fairly well and was eventually discharged on 2 days of doxycycline.  He cannot recall if was given convalescent plasma or remdesivir.  He was not discharged on dexamethasone on oxygen.  Immediately the next day he felt increasingly short of breath which has progressively gotten worse.  When he came to emergency department his oxygen saturations were 89% on room air.  Denies any fevers chills but he does have a nonproductive cough.
Patient was evaluated 1/16/23 at the ER by Dr. for cough, SOB and generalized weakness.  Patient was found to be covid-19 positive.  With symptom improvement patient was discharged home.  Patient returned later that day with c/o a fall at home where she hit her head.  Patient was evaluated and placed on observation status for continued evaluation and treatment as indicated.
Expired vaccine administered to 155 patients; WARNING: THE STUDY CONFIGURATION IS MISSING THE STUDY PHASE. PLEASE UPDATE THE STUDY PHASE AND RE-GENERATE THE NARRATIVE AGAIN.    This     The subject received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B). The report describes a case of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 155 patients).     No Medical History information was reported.  On 04-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 155 patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 155 patients) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product reported by reporter.  No treatment medication reported by reporter.   This case was linked to MOD-2022-551714.
On chest and back. Right side face. ?? Hx. Benzerdzed Portobesis.
I felt fine all day until about 11:30 pm. I had fallen asleep and woke up at that time with chills. The rest of the night I had chills and body aches.   The next day I continued to have chills, body aches, a very bad headache, dizziness, nausea, loss of appetite and I was very tired.   My arm did hurt for about an hour after the shot and was a little tender for a day or so but generally the arm was fine.    I did go to work the day after my vaccine, but was exhausted and went home and slept for the rest of the night.
Patient reported having a high grade fever (102.4) starting the day after injection; she also reported redness and swelling all the way around the injection site, with pain and heat; she visited the ER regarding this reaction.
pt recv vax 24OCT96 & the following day pt devel shoulder pain & an axillary lymphadenopathy (4cm) on the rt upper extremity;pt was seen in office on 28OCT96 & rxn was reported to have persisted @ time of report 29NOV96;
This spontaneous report was received from a medical assistant referring to an unspecified number of patients of unknown age and gender. No concurrent conditions, medical history and drug allergies were reported. On an unknown date, the patients were vaccinated with improperly stored doses of (Merck) VARIVAX (Lot number L003775 and expiry date 04-FEB-2017) (dosing regimen and route unknown). No concomitant medications were reported. No adverse effects were reported. Lot number L003775 with expiry date 04-FEB-2017 has been verified to be a valid lot number for (Merck) VARIVAX. Follow up information has ben received on 03-AUG-2015. Telephone call was made to the medical assistant. A voicemail message was left requesting she return the phone call. Additionally, a request was made for patient identifiers, lot number and expiration date and date of vaccination. All telephone attempts to obtain follow up information have been unsuccessful. Follow-up information has been received on 05-AUG-2015, a call was received from the certified medical assistant who reported that she would have to research the request made for patient identifiers, lot number, expiration date and dates of vaccination. The company fax number was reviewed with the reporter, if information becomes available. Follow-up information has been received from the medical assistant's clinic on 22-OCT-2015, regarding a 12-month-old (reported as 1-year-old) patient of unknown gender. On 14-SEP-2015, the patient was vaccinated with an improperly stored dose of (Merck) VARIVAX lot # L003775. The vaccine was purchased with public funds as a part of vaccine program. This is one of several reports received from the same source. Additional information has been requested. Patient's details, event information and narrative were updated.
Headache, elevated temp, fatigue, chills, injections site/local lymph node pain Narrative:
Get 2nd dose 10 months apart; This case was reported by a consumer via interactive digital media and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in May 2021).   In March 2022, the patient received the 2nd dose of Shingles vaccine. In March 2022, unknown after receiving Shingles vaccine, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK Receipt Date: 03-May-2022 Reporter's Comments: This case was reported by a patient via interactive digital media. The patient stated that since the doses were 10 months apart, did he/she need to get another shot. Additional Supportive Information: The patient received delayed 2nd Shingrix shot, which led to lengthening of vaccination schedule. The follow-up would not be possible as no contact details were available.
Tiredness that night, blurry sensation esp behind eyes. Following day continual headache and a fever . Woke up the following morning with no fever or headache but a battered body. Ive had Covid .. very similar to when I was ill only hopefully short lived . Cincerned about Vaccine 2 in a month which allegedly has stronger reactions.
Employee experienced diarrhea, nausea, stomach pain, headache, flushing, no fever. This lasted all day 12/24/2020 and part of the day 12/25/2020.
reports that 15 minutes after Pfizer vaccine she got extremely dizzy but sat back down and was ok.  On 07/07/2021 reports she woke up with a bad headache and extremely sore throat, muscle aches and fatigue which lasted for 4 1/2 days.  Then a chronic cough started and still continues today, 08-09-21 over a month from vaccine being given.  She says that her Doctor has told her not to get the 2nd vaccine of pfizer.
On 4/15/22 approximately 4:15 am I woke up with low grade fever, horrible headache, severe body aches, and just overall feeling sick. I took some NyQuil, ibuprofen and went back to bed, when I woke up at 8:00 I felt worse, nausea and diarrhea, and severally fatigued. I got a bottle of water, some Imodium, Zofran and went back to bed. This pretty much describes the next 4 days. I got dehydrated because nothing would stay in me, and over the counter meds didn?t do much for me.  Wednesday April 18 was the first day I really felt well enough to get out of bed and do much.
Joint aches; Fever 101.5; Vaccination site reaction; Back pain; headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Vaccination site reaction), BACK PAIN (Back pain), HEADACHE (headache), ARTHRALGIA (Joint aches) and PYREXIA (Fever 101.5) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 004M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE REACTION (Vaccination site reaction), BACK PAIN (Back pain) and HEADACHE (headache). On 10-Mar-2021, the patient experienced ARTHRALGIA (Joint aches) and PYREXIA (Fever 101.5). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE REACTION (Vaccination site reaction), BACK PAIN (Back pain), HEADACHE (headache), ARTHRALGIA (Joint aches) and PYREXIA (Fever 101.5) outcome was unknown.            Concomitant product use was not provided. Action taken with mRNA-123 is not applicable.
Fever 100.4, headache, stomach ache, emesis. Ate breakfast at school, then ran a mile in gym.
Left upper arm injection site sore beginning on day of injection and continued to be sore.   By Thursday, muscle from shoulder to elbow at a number 9 1/2 threshold and becoming 10+ upon movement. Tried heat, warm shower and Tylenol with kettle to no relief.
Pt recvd 1 dose of Engerix-B & in the following days exp not feeling good, dark urine, abdominal pain, nausea & no appetite for 10 days; sx resolved;
pt admitted w/sepsis synd 24 hrs pos vax cultures neg;pt expired;no autopsy;acute sepsis synd poss d/t vax
Large, raised, red, itchy, rash at site of injection appearing about a week after injection. It started as what looked like a large mosquito bite and quickly grew within a few hours to more than 3 inches in diameter. The area felt hard to the touch.  My upper arm was tender to touch and itchy.
Narrative: COVID infection following COVID vaccine series 01/14, Moderna , dose #1 02/12, Moderna , dose #2 10/27, Moderna , dose #3 09/13 COVID swab, result: detected 09/13 SARS-COV-E Variant Sequencing result: pending 09/15 pt cc: fever, myalgis, rhinorrhea, cough, dyspnea exposure: traveling
After administration, client slumped back in chair and eyes rolled back. Had client lean forward with head between knees and her mother and my supervisor assisted her up while I got ice pack. Had client lay on exam table with legs elevated. BP 120/90 P 64.  She lay there for about 5-10 minutes.  Took BP again 110/80 P 62.  She sat up and drank some water and ate a few crackers.  Sat up with legs dangling for a few minutes before standing after she said she was no longer feeling dizzy. Walked out with her and her mother and brother to make sure she got to car ok and suggested she rest and take it easy for the rest of the evening and to drink plenty of fluids and to eat well. Her mother said she had not had a former reaction to the vaccine (this was the third and final dose).
No further information is available; a patient received improperly stored vaccine on 8/20/2021; This spontaneous report was received from a medical assistant, referring to a 4-year-old male patient. The patient's pertinent medical history, concurrent conditions, concomitant medications, previous drug reactions, or allergies were not reported.  On 20-AUG-2021, the patient was vaccinated with one dose of an improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) injection (strength, vaccination scheme, anatomical site of vaccination, and route of administration were not reported; lot number U009262, expiration date was reported and validated as 19-SEP-2022) as prophylaxis (product storage error). No further information was available.  The vaccine underwent a temperature excursion of minus (-) 3.3 degrees Celsius (C) for 4 hours and 52 minutes. There was no previous temperature excursion.
Migraine symptoms. Couldn?t see, had blind spots, difficulty driving. Used cold compress on eyes and forehead in a dark room for 30 mins and symptoms seemed to go away.
Per mom, limp & minimally arouseable for @ least 12 hrs p/shot; no fever; not interested in feeding until qhs/overnight feedings; full recovery;
POSSIBLE SYNCOPE-PT FELT DIZZY PULSE WAS 51, BP WAS 133/91.  FRONT ASSOCIATE CALLED 911 AND AMBULANCE CAME AND  REFUSED TO GO AND WAS ABLE TO GET UP AND WALK OUT
3rd dose of Pfizer vaccine given 12 days short of the 5 month required window from dose 2 to 3. No adverse effects related to the vaccine occurred following the vaccination.
Fever, cough, chills, nausea, pain in diaphragm and lower back
Initially, I had flu like symptoms. I had a very sore arm, fever, and chills. The fatigue lasted quite a while. Now, I have a constant runny nose. I am achy. I have some joint discomfort. I went to my doctor and he said it was long haulers.
had 1st shot 2 years ago no 2nd shot; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received 2 years ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not applicable for this report. The pharmacist submitted afterhours web form on 20th September 2021 which was retrieved by medical information at start of business on 21st September 2021. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. No further details provided via form. The reporter did not consent to follow up.
The day after taking vaccine, I started joints and muscles pain in whole body, felt like my body is transforming. Then on second day after taking the vaccine my left leg and lower back hurts. Since then, I am having left leg and back pain because of which I can't even stand. I have to lay down or sit all the time. When I stand, my left leg pain increases to extremely high level and starts feeling numbness on the feet.
Mom called to clinic with c/o rash. Seen in clinic with more than or equal to 15 lesions that progressed while in clinic to more than 30 lesions.
Information has been received from a medical assistant referring to an unknown number of patients of unknown age and gender. Information concerning medical history, concurrent condition and concomitant therapy was not provided. On unknown dates, the patients were vaccinated with doses of GARDASIL (lot#, expiration date, dose and route not provided), which had been improperly stored. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Approximately 56.5 hours after my second Moderna vaccine shot, my husband and kids noticed a subconjunctival hemorrhage in my left eye. It resolved on it's own a few days later. The reason I thought I should report it  is that two other people I know also got the Moderna shot and then developed a subconjunctival hemorrhage. Thank you.